Evento coronariano agudo no paciente diabético (2023)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: DIABETES MELLITUS; CORONARIOPATIA
- Language: Português
- Imprenta:
- Publisher: Atheneu
- Publisher place: Rio de Janeiro
- Date published: 2023
- Source:
-
ABNT
GENESTRETI, Paulo Rizzo e BARACIOLI, Luciano Moreira e NICOLAU, Jose Carlos. Evento coronariano agudo no paciente diabético. Diabetes e doença cardiovaculares. Tradução . Rio de Janeiro: Atheneu, 2023. . . Acesso em: 27 jan. 2026. -
APA
Genestreti, P. R., Baracioli, L. M., & Nicolau, J. C. (2023). Evento coronariano agudo no paciente diabético. In Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu. -
NLM
Genestreti PR, Baracioli LM, Nicolau JC. Evento coronariano agudo no paciente diabético. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2026 jan. 27 ] -
Vancouver
Genestreti PR, Baracioli LM, Nicolau JC. Evento coronariano agudo no paciente diabético. In: Diabetes e doença cardiovaculares. Rio de Janeiro: Atheneu; 2023. [citado 2026 jan. 27 ] - P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes
- Impact of the Extent of Coronary and Myocardial Disease on the Treatment Effect of Surgical Revascularization in Patients With Ischemic Left Ventricular Dysfunction
- Doença arterial coronariana aguda
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
- Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor for the prevention of ischemic events in patients with prior myocardial infarction and peripheral artery disease
- Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
